WeightWatchers stock surges 70% after company agrees to buy obesity treatment platform

Business

In this article

Weight Watchers brand ice cream in a supermarket freezer in New York.
Richard Levine | Corbis News | Getty Images

Shares of WW International, also known as WeightWatchers, skyrocketed Tuesday after the company said it planned to buy Sequence, a telehealth platform that provides treatment for obesity.

The stock closed 79% higher on Tuesday. Its market value stood at more than $488 million.

“It is our responsibility, as the trusted leader in weight management, to support those interested in exploring if medications are right for them,” WW CEO Sima Sistani said in a Monday announcement.

Tuesday’s jump follows a year of sagging performance for the stock. Shares of the company were down 57% over the past year as it struggled to pivot to wellness and move away from weight loss.

Sistani took over as chief executive at the end of February, steering the company back toward weight loss messaging.

The Sequence announcement comes as companies across the weight loss industry look to offer obesity medications as a pathway to customers looking to shed pounds.

The trend has led to a shortage in medications like Ozempic, which are commonly prescribed for Type 2 diabetes.

Products You May Like

Articles You May Like

Why ‘Serial’ Turned to Guantánamo: “This Place Is Crazy and Nobody Knows About It”
Alderbrook Resort & Spa is My Summer Camp Dream Come True
Jeremy Renner Returns to Action in Mayor of Kingstown Season 3 Teaser: Watch
There’s Always This Year
A New Stephen King Adaptation Has Been Secretly Filming, And The Movie Features An Awesome Cast

Leave a Reply

Your email address will not be published. Required fields are marked *